Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-25 @ 9:28 PM
NCT ID:
NCT03478956
Pre Assignment Details:
The study was conducted in 3 parts: Randomized Treatment Period, Open-label Extension (OLE) Period and Progressive Multifocal Leukoencephalopathy (PML) Safety Monitoring (SM) Period. Participants who completed the randomized treatment period were given the option to continue treatment in OLE period. After the randomized treatment period (if they did not enter OLE) or after the OLE period, participants were given the option to continue in PML SM period during which they were monitored for PML.
Study:
NCT03478956
Study Brief:
Results Section:
NCT03478956